Boehringer Ingelheim
Mark Petronczki serves as the Head of Oncology Research and Global Head of Research Beyond Borders at Boehringer Ingelheim from December 2020 to December 2024. Previously, Mark held positions as Senior Group Leader and Junior Group Leader at Cancer Research UK from September 2007 to September 2014, and worked as a Postdoctoral Research Fellow at the Research Institute of Molecular Pathology from October 2000 to August 2007, focusing on the function of Polo-like kinase 1 in human cells. Mark earned a Doctor of Philosophy (Ph.D.) in Genetics from the University of Vienna and has additional educational credentials in Biology and Genetics from the Research Institute of Molecular Pathology.
This person is not in any teams
This person is not in any offices